Hjem › Parkinsons sykdom › New York › New York City
Kliniske studier for Parkinsons sykdom i New York City, NY
23 studier for Parkinsons sykdom søker deltakere på steder i og rundt New York City (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease
RekruttererFase 2
- Icahn School of Medicine at Mount Sinai/Mount Sinai West, New York
- Columbia University, New York
Visual Hallucinations in Lewy Body Diseases
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- NYU Langone Health, New York
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease
RekruttererFase 2/3
- Site-005, New York
GBPDC: Gut-Brain in PD Consortium Master Protocol
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Columbia University, New York
Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease
RekruttererFase 2
- Weill Cornell Medical College, New York
A Study of Buntanetap in Participants With PD
RekruttererFase 2/3
- Mount Sinai Hospital, New York
A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
RekruttererFase 2
- Vima Site #024, New York
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
RekruttererFase 2
- Joan and Sanford I. Weill Department of Medicine (Site #224), New York
- Mount Sinai School of Medicine (Site #209), New York
Parkinson's Foundation PD GENEration Genetic Registry
RekruttererObservasjonsstudie
- Mount Sinai, New York
- Columbia University, New York
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications
RekruttererObservasjonsstudie
- Northwell Health, New York
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
RekruttererFase 3
- Weill Cornell Medical College, New York
- Columbia University Medical Center, New York
Young Onset Parkinson's Disease Subtypes and Pathogenic Mechanisms
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- NYU Langone Health, New York
Autoimmune Features of Neurodegenerative Disorders
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Columbia University Medical Center, New York
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's Disease
RekruttererFase 3
- Mount Sinai West - Neurology, New York
- New York Presbyterian/Weill Cornell Medical Center, New York
Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's Disease
Rekrutterer
- Radial Midtown Manhattan, New York
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Beth Israel Medical Center, New York
- NYU Langone Health, New York
Natural History Study of Synucleinopathies
RekruttererObservasjonsstudie
- NYU Medical Center, New York
Parkinson's Disease Biomarkers in Nerve Cells in the Gut
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Weill Cornell Medicine, New York
This Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibility and Preliminary Efficacy of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in Patients With Parkinson's Disease.
RekruttererFase 1/2
- Cornell University Weill Medical College, New York
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications
RekruttererObservasjonsstudie
- Weill Cornell Medicine, New York
A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's Disease
RekruttererFase 1/2
- New York Presbyterian Hospital-Columbia University Medical Center, New York
NYSCF Scientific Discovery Biobank
RekruttererObservasjonsstudie
- New York Stem Cell Foundation Research Institute, New York
Noise-augmented Automatic Speech Recognition for Speech Treatment in Parkinson's Disease
RekruttererTidlig fase 1
- Teachers College, Columbia University, New York
Parkinsons sykdom-studier i andre byer
- Boston, MA19 studier
- Cleveland, OH18 studier
- Minneapolis, MN17 studier
- Nashville, TN15 studier
- Philadelphia, PA14 studier
- San Francisco, CA14 studier
- New Haven, CT14 studier
- Charleston, SC13 studier
- Farmington Hills, MI13 studier
- Chicago, IL13 studier
- Miami, FL13 studier
- Aurora, CO12 studier
Andre studier i New York City
- Brystkreft136 studier
- Ikke-småcellet lungekreft121 studier
- Kreft (alle typer)109 studier
- Prostatakreft103 studier
- Metastatisk kreft93 studier
- Kolorektal kreft78 studier
- Eggstokkreft69 studier
- Lungekreft60 studier
- Multipelt myelom60 studier
- Pankreaskreft60 studier
- Endometriekreft52 studier
- Akut myelogen leukemi51 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.